about
Kinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitorsRegarding "meta-analysis and causal inference: a case study of benzene and non-Hodgkin lymphoma": an incomplete analysisRisk of death for hematological malignancies for residents close to an Italian petrochemical refinery: a population-based case-control studySpatial variation in mortality risk for hematological malignancies near a petrochemical refinery: A population-based case-control studyEfficacy, safety and quality-of-life associated with lenalidomide plus dexamethasone for the treatment of relapsed or refractory multiple myeloma: the Spanish experience.Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use.Diagnostic predictive value of platelet indices for discriminating hypo productive versus immune thrombocytopenia purpura in patients attending a tertiary care teaching hospital in Addis Ababa, Ethiopia.Diagnosed hematological malignancies in Bangladesh - a retrospective analysis of over 5000 cases from 10 specialized hospitals.Developmental exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin attenuates capacity of hematopoietic stem cells to undergo lymphocyte differentiation.Long-term effects and psychological adjustment: study protocol of a large register-based study on quality of life among survivors of hematological malignancies.Constitutive MAP kinase activation in hematopoietic stem cells induces a myeloproliferative disorder.p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysisA phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group report.Wnt-4 protects thymic epithelial cells against dexamethasone-induced senescence.Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis.The epidemiological features of lymphoid malignancies in Benin City, Nigeria: a 15 years study.Hematological malignancies in Al-amal oncology unit, adenDistribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 yearsGenetic lesions in diffuse large B-cell lymphomasBMP signalling differentially regulates distinct haematopoietic stem cell typesEthnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and PalestiniansA systematic review of prognostic factors at the end of life for people with a hematological malignancyIs there a true concern regarding the use of hair dye and malignancy development?: a review of the epidemiological evidence relating personal hair dye use to the risk of malignancy.Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease.Very high birth weight of offspring is associated with an increased risk of leukemia in their mothers: results of a population-based cohort studyEmerging metabolic targets in the therapy of hematological malignancies.HDAC inhibitor-based therapies and haematological malignancy.Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis.Chemotherapy alone or combined chemotherapy and involved field radiotherapy in favorable risk early-stage classical Hodgkin lymphoma-a 10 years experience.Relationship between baseline white blood cell count and renal and hepatic function in older patients with acute myeloid leukemiaEpidemiology and outcome of Rhodotorula infection in haematological patients.Intensive care of the cancer patient: recent achievements and remaining challengesThymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis.Severe combined immunodeficiences: new and old scenarios.Microarray expression profiles of long non-coding RNAs in germinal center-like diffuse large B-cell lymphoma.Kidney diseases associated with haematological cancers.Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy.What are the barriers of quality survivorship care for haematology cancer patients? Qualitative insights from cancer nurses.Understanding the information needs of people with haematological cancers. A meta-ethnography of quantitative and qualitative research.
P2860
Q26849792-6C49C65E-482E-41CB-9E3D-05DF5E9BE710Q28393100-EE8B9C6D-79A4-4141-9C30-4D4662568F41Q28397774-C6BE58C4-74B1-45C1-9DC8-D8526AA947CAQ28397835-6A444238-4EA1-442C-AD18-C9CA3C1BEBBEQ33399416-F3AC8088-97DC-415A-9FEF-4F8CF11933D7Q33401766-A43D1971-0819-464C-B02C-D1F1C27D1FF9Q33431584-2FF9AEC0-2664-40D3-A5EC-406A3008D010Q33433610-9C737EBA-FC9E-47FB-9FE5-7B9632C0D1C3Q33776711-56C9B6F2-15F7-4596-8BB0-958D169DCB2CQ33851883-6EBE227C-1F1C-4C5B-BF61-5506397B0115Q33901198-5D15CD3F-D704-4496-8095-6E9180845525Q34099193-8FE6E967-2044-43BD-86BB-A33FA21DEA72Q34430158-795EF70D-23E7-44A7-ADF0-153B20859F5FQ35061729-48EBA22A-AED9-40E9-B81D-4A3B223A87BAQ35106636-AEA4529A-6D20-49E7-833B-88D8EE69C5CCQ35211371-F05FE00E-FFDA-4A21-B3EC-B4068211B8A8Q35767621-F578E6EF-BEA6-45EE-A391-DDBFCE34DE0BQ35851663-A1130C91-332E-43FB-8D85-78B35D80B06AQ35936061-B65E8D8D-F2B5-417A-8C1B-51433DDF331BQ35974341-202F35D7-C087-4FBA-80A8-FB13DF92D4F0Q36018760-4FD71A84-8B57-475C-968A-E58C524B557FQ36280035-67DDA0CC-39D4-4B4A-A1D3-B57D71887300Q36320935-F1513DD9-54BD-427F-B2EA-11763F1FB442Q36527092-2FF1B399-1314-462E-9DA7-C14B6B3F9445Q36638675-802584E1-61EB-4D49-B3E7-613AB356F6D9Q36946640-2132425E-25C8-4346-AD36-D459BBC23C55Q37137623-C001BDF4-D598-4C82-9FFD-F9E8673E2C57Q37514642-42B81304-0C25-4173-8D28-825182C4E788Q37538571-E4C4CF52-1557-4721-8FF2-66781EDCBFBBQ37563122-5F9554E3-4342-444A-AB6A-6F0C0FD2514CQ37611616-309D1E6D-B0EE-4EAB-876A-B877E4760AF8Q37718939-5206BF2E-7E32-4AC6-8EB0-D7B83F382B02Q37929882-BF559C6E-F2FC-4765-8D8C-9715A46C856AQ37967954-961D354E-A6F6-42A5-BC70-94FB4DBE12C7Q37976472-B5F50114-AC68-4B2A-B3B6-7C3C56BE08C1Q38431170-9AB9833E-2000-4A56-A63F-B90A7916869AQ38513113-842B7BD5-11D5-446C-9DA1-05C1A1242E4BQ38843265-D2979CD0-C277-4E23-A571-D43E00C8CE87Q39001356-7E27A2AC-7DBB-4163-ACD0-73FA78F1CCF4Q39129451-5080087E-CFC4-4878-9829-2966EAF88D85
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Epidemiology of hematological malignancies.
@ast
Epidemiology of hematological malignancies.
@en
type
label
Epidemiology of hematological malignancies.
@ast
Epidemiology of hematological malignancies.
@en
prefLabel
Epidemiology of hematological malignancies.
@ast
Epidemiology of hematological malignancies.
@en
P2093
P356
P1433
P1476
Epidemiology of hematological malignancies.
@en
P2093
D Rodriguez-Abreu
P356
10.1093/ANNONC/MDL443
P478
18 Suppl 1
P577
2007-01-01T00:00:00Z